Efficacy and safety of larotrectinib in adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system tumors Meeting Abstract
| Authors: | Perreault, S.; van Tilburg, C. M.; Geoerger, B.; Nysom, K.; Ora, I.; Gavrilovic, I. T.; Norenberg, R.; Dima, L.; De La Cuesta, E. A.; Drilon, A. E.; Doz, F. P. |
| Abstract Title: | Efficacy and safety of larotrectinib in adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system tumors |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120600287 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.2002 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2002 -- Source: Wos |
